Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep
  Brain Stimulation for Parkinson's Disease
From: Medical Design Technology - 11/09/2010
By: Boston Scientific

Boston Scientific Corporation today announced the first implantation of its
Vercise Deep Brain Stimulation (DBS) System as part of the VANTAGE clinical
trial.  VANTAGE is a multi-center, prospective trial designed to examine the
improvement of motor function in approximately 40 European patients implanted
with the Vercise DBS System for the treatment of Parkinson's disease. 

The Vercise Deep Brain Stimulation System is a neurostimulation device
designed to deliver electrical signals to specific areas within the brain
through individual lead contacts that allow a more tailored amount of current
flow based on patient needs. 

Read the entire article at:
http://www.mdtmag.com/News/Feeds/2010/11/device-sectors-neurology-boston-scientific-begins-patient-enrollment-in-cli/